MGIC Investment
MTG NYSE Reinsurance Financials FY2016βFY2025
MGIC Investment's revenue rose 0.5% to $1.2 billion in fiscal 2025. Its net margin was 60.8%, down from 63.2% a year earlier. Free cash flow was $852 million, up 17.7%. It paid out $921 million in dividends and buybacks, 108% of free cash flow. The diluted share count fell 10.9%.
What MGIC Investment does
No business description yet.
- Legal name
- MGIC Investment Corp
- Fiscal year ends
- December 31, 2025
- Latest annual report
- β
- Accession Β· CIK
- 0000876437-26-000010
0000876437
Revenue and margins
MGIC Investment had $1.2B of revenue in fiscal 2025, up 0.5% on the year before.
Net income and earnings per share
From fiscal 2016 to 2025, diluted EPS grew 15.5% a year. Loss periods are shown in red.
Returns on capital
After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
Cash flow
Free cash flow was $852M in fiscal 2025, 70.2% of revenue. Cash from operations minus capital spending.
Dividends, buybacks and share count
MGIC Investment returned $921M to shareholders in fiscal 2025, 108% of free cash flow. The diluted share count fell 11.0%.
Value MGIC Investment yourself
Change the assumptions and see what they imply per share. These are models, not forecasts or price targets β the answer depends entirely on what you put in.
Discounted cash flow
Value per share
β
Adds net cash of β and divides by 235.1M diluted shares. Ten years of cash flows plus a terminal value, discounted to today.
Earnings multiple
Value per share
β
Reference multiples: today 9.0x Β· peers 8.9x Β· sector 13.7x.
Balance sheet
Cash, debt and the ratios that show how comfortably MGIC Investment can carry it.
| Fiscal year end | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Cash and short-term investments | $285M | $327M | $364M | $230M | $369M |
| Debt incl. finance leases | $1.1B | $663M | $643M | β | β |
| Net debt / EBITDA | 0.9x | 0.3x | 0.3x | β | β |
| Debt / equity | 0.2x | 0.1x | 0.1x | β | β |
| Interest coverage | 12.2x | 23.7x | 25.5x | 28.2x | 27.1x |
| Total assets | $7.3B | $6.2B | $6.5B | $6.5B | $6.6B |
| Total liabilities | $2.5B | $1.6B | $1.5B | $1.4B | $1.5B |
| Shareholders' equity | $4.9B | $4.6B | $5.1B | $5.2B | $5.1B |
| Net debt (β = net cash) | $862M | $335M | $280M | β | β |
Insider trades
Open-market purchases and sales by officers, directors and 10% owners, from Form 4 filings. 'Plan' marks trades under a pre-arranged Rule 10b5-1 plan.
Bought, 12 months
$0.0M
0 insiders
Sold, 12 months
$14.7M
4 insiders
Of sales under plans
100%
$14.7M
| Date | Insider | Trade | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| Sep 24, 2026 | Nathaniel H ColsonOfficer EVP, CFO & CRO | Sold plan | 20,000 | $29.48 | $0.6M | Form 4 |
| Sep 1, 2026 | Salvatore A MiosiPresident & COO | Sold plan | 30,000 | $30.73 | $0.9M | Form 4 |
| Aug 7, 2026 | Paula C MaggioEVP and General Counsel | Sold plan | 20,000 | $30.30 | $0.6M | Form 4 |
| Aug 5, 2026 | Timothy J. MattkeChief Executive Officer, Director | Sold plan | 137,113 | $30.52 | $4.2M | Form 4 |
| Aug 3, 2026 | Salvatore A MiosiPresident & COO | Sold plan | 30,000 | $29.70 | $0.9M | Form 4 |
| Jul 1, 2026 | Salvatore A MiosiPresident & COO | Sold plan | 30,000 | $28.23 | $0.8M | Form 4 |
| Jun 25, 2026 | Nathaniel H ColsonOfficer EVP, CFO & CRO | Sold plan | 20,000 | $27.10 | $0.5M | Form 4 |
| Jun 8, 2026 | Salvatore A MiosiPresident & COO | Sold plan | 30,000 | $25.38 | $0.8M | Form 4 |
| May 29, 2026 | Paula C MaggioEVP and General Counsel | Sold plan | 20,937 | $25.55 | $0.5M | Form 4 |
| Apr 2, 2026 | Timothy J. MattkeChief Executive Officer, Director | Sold plan | 139,202 | $26.49 | $3.7M | Form 4 |
| Apr 1, 2026 | Salvatore A MiosiPresident & COO | Sold plan | 10,931 | $26.25 | $0.3M | Form 4 |
| Mar 2, 2026 | Salvatore A MiosiPresident & COO | Sold plan | 30,000 | $27.04 | $0.8M | Form 4 |
Piotroski F-score
Nine pass/fail tests of profitability, funding and efficiency. 8β9 is strong, 0β2 weak.
| Test | FY23 | FY24 | FY25 |
|---|---|---|---|
| Net income is positive | β | β | β |
| Cash from operations is positive | β | β | β |
| Return on assets rose | β | β | β |
| Cash from operations exceeds net income | β | β | β |
| Debt fell relative to assets | β | β | β |
| Current ratio rose | β | β | β |
| Share count didn't rise | β | β | β |
| Gross margin rose | β | β | β |
| Revenue rose relative to assets | β | β | β |
| F-score | β / 9 | β / 9 | β / 9 |
| Accruals ratio | 0.0% | 0.6% | β1.7% |
| Altman Z'' | β | β | β |
Similar companies
Each company's latest fiscal year. Fiscal years end in different months, so periods don't line up exactly.
| Company | Market cap | Growth | Op. margin | FCF margin | ROIC | P/E | F-score | |
|---|---|---|---|---|---|---|---|---|
| MGIC Investment MTG | $6.1B | 0.5% | β | 70.2% | β | 9.0x | β | |
| RenaissanceRe RNR | $14.6B | 9.9% | β | β | 54.2% | 6.3x | β | Compare β |
| Everest Group EG | $15.5B | 1.2% | β | β | β | 8.4x | β | Compare β |
| Reinsurance Group of America RGA | $17.4B | 7.2% | β | β | β | 11.6x | β | Compare β |
| Essent Group ESNT | $6.1B | 1.5% | β | 67.3% | β | 9.3x | β | Compare β |
10 years of figures
US$ millions unless stated. Hover a ratio's name for its definition.
| Fiscal year | FY16 | FY17 | FY18 | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||||
| Revenue | $1.1B | $1.1B | $1.1B | $1.2B | $1.2B | $1.2B | $1.2B | $1.2B | $1.2B | $1.2B |
| Interest expense | $56.7M | $57.0M | $53.0M | $52.7M | $59.6M | $71.4M | $48.1M | $36.9M | $35.6M | $35.6M |
| Pretax income | $515M | $785M | $844M | $848M | $559M | $802M | $1.1B | $902M | $969M | $929M |
| Income tax | $172M | $429M | $174M | $174M | $113M | $167M | $225M | $189M | $206M | $190M |
| Net income | $343M | $356M | $670M | $674M | $446M | $635M | $865M | $713M | $763M | $738M |
| Diluted EPS | $0.86 | $0.95 | $1.78 | $1.85 | $1.29 | $1.85 | $2.79 | $2.49 | $2.89 | $3.14 |
| Diluted shares | 0.43B | 0.39B | 0.39B | 0.37B | 0.36B | 0.35B | 0.31B | 0.29B | 0.26B | 0.24B |
| Cash flow | ||||||||||
| Cash from operations | $225M | $407M | $545M | $610M | $732M | $696M | $650M | $713M | $725M | $853M |
| Capital expenditure | $10.6M | $16.1M | $14.2M | $5.6M | $3.3M | $4.1M | $3.3M | $2.0M | $1.2M | $1.0M |
| Free cash flow | $214M | $391M | $530M | $604M | $729M | $692M | $647M | $711M | $724M | $852M |
| Depreciation and amortization | $61.3M | $64.4M | $58.2M | $48.8M | $57.8M | $66.0M | $54.3M | $35.2M | $18.4M | $6.9M |
| Stock-based compensation | $11.4M | $14.9M | $20.9M | $18.9M | $13.8M | $17.1M | $24.8M | $31.6M | $31.3M | $24.4M |
| Acquisitions | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M |
| Share buybacks | $147M | $0.0M | $163M | $126M | $120M | $291M | $386M | $337M | $570M | $789M |
| Dividends paid | $0.0M | $0.0M | $0.0M | $41.9M | $82.1M | $94.2M | $111M | $123M | $131M | $133M |
| Dividends and buybacks | $147M | $0.0M | $163M | $168M | $202M | $385M | $497M | $460M | $700M | $921M |
| Balance sheet | ||||||||||
| Cash and short-term investments | $155M | $99.9M | $152M | $162M | $288M | $285M | $327M | $364M | $230M | $369M |
| Total debt | $1.2B | $830M | $832M | $833M | $1.2B | $1.1B | $663M | $643M | β | β |
| Finance lease liabilities | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M |
| Inventory | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M |
| Property and equipment, net | $36.1M | $44.9M | $51.7M | $50.1M | $47.1M | $45.6M | $41.4M | $38.8M | $35.7M | $32.5M |
| Total assets | $5.7B | $5.6B | $5.7B | $6.2B | $7.4B | $7.3B | $6.2B | $6.5B | $6.5B | $6.6B |
| Total liabilities | $3.2B | $2.5B | $2.1B | $1.9B | $2.7B | $2.5B | $1.6B | $1.5B | $1.4B | $1.5B |
| Shareholders' equity | $2.5B | $3.2B | $3.6B | $4.3B | $4.7B | $4.9B | $4.6B | $5.1B | $5.2B | $5.1B |
| Margins | ||||||||||
| EBITDA margin | 59.6% | 85.0% | 85.0% | 78.2% | 56.4% | 79.2% | 101.7% | 84.4% | 84.7% | 80.0% |
| Net margin | 32.2% | 33.4% | 59.6% | 55.5% | 37.2% | 53.6% | 73.8% | 61.7% | 63.2% | 60.8% |
| FCF margin | 20.2% | 36.6% | 47.2% | 49.8% | 60.8% | 58.4% | 55.2% | 61.6% | 59.9% | 70.2% |
| Returns | ||||||||||
| Return on capital | 11.1% | 11.3% | 17.5% | 15.5% | 9.3% | 12.2% | 16.9% | 14.4% | β | β |
| Return on equity | 14.3% | 12.5% | 19.9% | 17.1% | 9.9% | 13.3% | 18.2% | 14.7% | 14.9% | 14.3% |
| Return on assets | 5.9% | 6.3% | 11.9% | 11.3% | 6.6% | 8.7% | 12.8% | 11.2% | 11.7% | 11.2% |
| Growth | ||||||||||
| Revenue growth | 2.0% | 0.3% | 5.4% | 8.0% | β1.2% | β1.1% | β1.1% | β1.5% | 4.6% | 0.5% |
| Net income growth | β70.8% | 3.9% | 88.4% | 0.6% | β33.8% | 42.3% | 36.3% | β17.6% | 7.0% | β3.2% |
| EPS growth | β66.9% | 10.5% | 87.4% | 3.9% | β30.3% | 43.4% | 50.8% | β10.8% | 16.1% | 8.7% |
| FCF growth | 36.6% | 82.3% | 35.8% | 13.9% | 20.7% | β5.1% | β6.6% | 9.9% | 1.8% | 17.7% |
| Share count change | β7.7% | β8.6% | β2.2% | β3.2% | β3.9% | β2.2% | β11.4% | β7.7% | β8.1% | β11.0% |
| Financial health | ||||||||||
| Net debt / EBITDA | 1.6x | 0.8x | 0.7x | 0.7x | 1.4x | 0.9x | 0.3x | 0.3x | β | β |
| Debt / equity | 0.5x | 0.3x | 0.2x | 0.2x | 0.3x | 0.2x | 0.1x | 0.1x | β | β |
| Interest coverage | 10.1x | 14.8x | 16.9x | 17.1x | 10.4x | 12.2x | 23.7x | 25.5x | 28.2x | 27.1x |
| Capital allocation | ||||||||||
| Capex / revenue | 1.0% | 1.5% | 1.3% | 0.5% | 0.3% | 0.4% | 0.3% | 0.2% | 0.1% | 0.1% |
| Stock comp / revenue | 1.1% | 1.4% | 1.9% | 1.6% | 1.2% | 1.4% | 2.1% | 2.7% | 2.6% | 2.0% |
| Payouts / FCF | 68.7% | 0.0% | 30.8% | 27.8% | 27.7% | 55.6% | 76.8% | 64.7% | 96.7% | 108.1% |
| Quality scores | ||||||||||
| Accruals ratio | 2.0% | β0.9% | 2.2% | 1.1% | β4.2% | β0.8% | 3.2% | 0.0% | 0.6% | β1.7% |
Source: SEC EDGAR XBRL filings (CIK 0000876437). Data updated October 18, 2026. Quarterly fourth quarters are the full year minus the first nine months. For information only β not investment advice. Check the original filings before relying on any figure.